We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$31B
AUM Growth
+$5.1B
Cap. Flow
+$4.42B
Cap. Flow %
14.26%
Top 10 Hldgs %
15.35%
Holding
1,525
New
241
Increased
776
Reduced
376
Closed
66

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$132M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$114M
3
AMZN icon
Amazon
AMZN
+$89.2M
4
MSFT icon
Microsoft
MSFT
+$88.1M
5
META icon
Meta Platforms (Facebook)
META
+$85M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$105M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$64.5M
3
YHOO
Yahoo Inc
YHOO
+$41.6M
4
CUK
Carnival PLC
CUK
+$36.5M
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$31.3M

Sector Composition

Rank Sector Weight
1 Financials 17.48%
2 Technology 15.7%
3 Healthcare 13.87%
4 Industrials 10.19%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACGN
1426
DELISTED
Aceragen Inc
ACGN
$136K ﹤0.01%
+581
New +$152K
MACK
1427
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$134K ﹤0.01%
+13,727
New +$280K
PVLA
1428
Palvella Therapeutics
PVLA
$2.23B
$132K ﹤0.01%
+325
New +$95K
IBRX icon
1429
ImmunityBio
IBRX
$8.2B
$129K ﹤0.01%
+17,000
New +$73.4K
VRDN icon
1430
Viridian Therapeutics
VRDN
$2.59B
$129K ﹤0.01%
+667
New +$113K
KIN
1431
DELISTED
Kindred Biosciences, Inc.
KIN
$129K ﹤0.01%
+15,000
New +$108K
ARDX icon
1432
Ardelyx
ARDX
$1.03B
$128K ﹤0.01%
+25,000
New +$212K
LUMO
1433
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$125K ﹤0.01%
+1,889
New +$234K
GNCA
1434
DELISTED
Genocea Biosciences, Inc.
GNCA
$125K ﹤0.01%
+3,000
New +$144K
ABEO icon
1435
Abeona Therapeutics
ABEO
$425M
$122K ﹤0.01%
+760
New +$104K
FBIO icon
1436
Fortress Biotech
FBIO
$91.4M
$119K ﹤0.01%
+1,667
New +$98.4K
IMDZ
1437
DELISTED
Immune Design Corp.
IMDZ
$117K ﹤0.01%
+12,000
New +$84.2K
HSTO
1438
DELISTED
Histogen Inc. Common Stock
HSTO
$115K ﹤0.01%
+100
New +$122K
SBBP
1439
DELISTED
Strongbridge Biopharma plc.
SBBP
$114K ﹤0.01%
+16,000
New +$74K
ATHX
1440
DELISTED
Athersys, Inc. Common Stock
ATHX
$113K ﹤0.01%
+3,000
New +$112K
CORI
1441
DELISTED
Corium International, Inc.
CORI
$112K ﹤0.01%
+15,000
New +$89.2K
CASC
1442
DELISTED
Cascadian Therapeutics, Inc.
CASC
$104K ﹤0.01%
+28,000
New +$111K
KURA icon
1443
Kura Oncology
KURA
$882M
$102K ﹤0.01%
+11,000
New +$100K
NEOS
1444
DELISTED
Neos Therapeutics, Inc
NEOS
$102K ﹤0.01%
+14,000
New +$106K
NVLN
1445
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$102K ﹤0.01%
+11,000
New +$106K
FATE icon
1446
Fate Therapeutics
FATE
$317M
$97K ﹤0.01%
+30,000
New +$115K
NYMX
1447
DELISTED
Nymox Pharmaceutical Corp
NYMX
$97K ﹤0.01%
+22,000
New +$90.3K
TRVN
1448
DELISTED
Trevena, Inc.
TRVN
$92K ﹤0.01%
+64
New +$118K
VYGR icon
1449
Voyager Therapeutics
VYGR
$197M
$90K ﹤0.01%
+10,000
New +$101K
SCTL
1450
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$77K ﹤0.01%
+12,265
New +$84K
56 57
58
59 60

Similar funds

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State of Wisconsin Investment Board's Q2 2017 Portfolio in Review

As of Q2 2017, State of Wisconsin Investment Board held 1,525 positions worth $31B, up 20% from $25.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

State of Wisconsin Investment Board deployed $4.42B of net new capital in Q2 2017, opening 241 new positions and adding to 776 existing holdings. Its largest new stake was Altaba Inc: 1,221,540 shares worth $66.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $64.5M trimmed.

  • State of Wisconsin Investment Board's largest Q2 2017 buy was Altaba Inc: 1,221,540 shares worth $66.5M.
  • State of Wisconsin Investment Board added most to Apple in Q2 2017, an estimated $132M increase.
  • State of Wisconsin Investment Board's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $64.5M.
  • State of Wisconsin Investment Board fully exited State Street SPDR S&P Biotech ETF in Q2 2017, selling an estimated $105M.
  • State of Wisconsin Investment Board's ten largest holdings make up 15% of its $31B portfolio in Q2 2017.
  • State of Wisconsin Investment Board opened 241 new positions and closed 66 in Q2 2017.
  • State of Wisconsin Investment Board's portfolio value rose 20% quarter-over-quarter to $31B.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2017, filed 3 Aug 2017.